Signaling pathways
-
BA6016 IL-15-IN-1Summary: IL-15-IN-1 is a potent, selective IL-15-dependent cytostatic. - BA6017 VeledimexSummary: Veledimex (INXN-1001) is a synthetic analog of the insect ecdysone ecdysone, an orally active activating ligand for use in a proprietary gene therapy promoter system.
- BA6018 YQ128Summary: YQ128 is a potent, selective second-generation inhibitor.
- BA6019 PivekimabSummary: Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).
- BA6020 AngolineSummary: Angoline is a potent and selective inhibitor of signaling pathways.
- BA6021 SonelokimabSummary: Sonelokimab (ALX0761; M1095) is a trivalent nanobody composed of monovalent camel-derived nanobodies specific for human interleukin (IL)-17A, IL-17F and human serum albumin VHH.
- BA6022 GIBH-130Summary: GIBH-130 is a potent neuroinflammatory inhibitor.
- BA6023 OrdesekimabSummary: Ordesekimab (AMG714; PRV-015) is a human IgG1κ anti-monoclonal antibody.
- BA6024 NepetinSummary: Nepetin is a natural flavonoid isolated from HBK with potent anti-inflammatory activity.
- BA6025 RilonaceptSummary: Rilonacept (Arcalyst) is a dimeric fusion protein that is an interleukin 1 inhibitor.